Dick de Zeeuw - Publications, H-index & Citations

Back

Dick de Zeeuw

University Medical Centre Groningen

118H-index

1.2KPaper Count

10.1WCitation Count

Published Papers 357

Publication Date

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses

diabetes, obesity and metabolism

IF0

2026-05-05

OAAI

David Z. I. Cherney; Peter Rossing; Maria Eugenia Canziani; Maria Luiza Caramori; Ricardo Correa-Rotter; Lisa Cronin; Christian Hugo; Bo Ji; Juliane Meyerhoff; Masaomi Nangaku; Arnold Silva; Dorothea Urbach; Shimoli V. Shah; Dick de Zeeuw; Katherine R. Tuttle

Save

Randomized Clinical Trial of the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status

Kidney International Reports

IF5.7

2026-04-16

OAAI

Ricardo Correa-Rotter; Peter RossingMD; Maria Eugenia Canziani; Maria Luiza Caramori; David Z.I. Cherney; Lisa Cronin; Christian Hugo; Bo Ji; Juliane Meyerhoff; Masaomi Nangaku; Arnold Silva; Dorothea Urbach; Shimoli V. Shah; Dick de Zeeuw; Katherine R. Tuttle

Save

Cumulative Effects of Vicadrostat and Empagliflozin on Albuminuria in CKD

American Journal of Kidney Diseases

IF8.2

2026-02-10

OAAI

Peter Rossing; Sibylle J. Hauske; Maria Eugenia Canziani; Maria Luiza Caramori; David Z.I. Cherney; Ricardo Correa-Rotter; Christian Hugo; Masaomi Nangaku; Arnold Silva; Dorothea Urbach; Dick de Zeeuw; Juliane Meyerhoff; Lisa Cronin; Zhichao Sun; Shimoli V. Shah; Katherine R. Tuttle

Save

Effects of vicadrostat with and without empagliflozin in people with chronic kidney disease by baseline BMI

Nephrology Dialysis Transplantation

IF5.6

2025-10-01

OAAI

Rossing, Peter; Hauske, Sibylle; Cronin, Lisa; Heerspink, Hiddo J. L.; Meyerhoff, Juliane; Ji, Bo; de Zeeuw, Dick; Tuttle, Katherine R.

Save

Vicadrostat with and without empagliflozin reduces albuminuria across KDIGO risk class in chronic kidney disease

Nephrology Dialysis Transplantation

IF5.6

2025-10-01

OAAI

Tuttle, Katherine R.; Hauske, Sibylle; Cronin, Lisa; Heerspink, Hiddo J. L.; Meyerhoff, Juliane; Ji, Bo; de Zeeuw, Dick; Rossing, Peter

Save

Kidney and cardiac biomarkers and risk of adverse kidney outcomes in patients with type 2 diabetes and kidney disease, cardiovascular disease, or both

CIRCULATION

IF38.6

2024-11-12

PREAI

Mc Causland, Finnian; Claggett, Brian; Solomon, Scott; Chaturvedi, Nishi; de Zeeuw, Dick; Malachias, Marcus; McGrath, Martina; McMurray, John; Neuen, Brendon; Vaduganathan, Muthiah

Save

Systolic plood pressure response to ASi BI 690517 with and without empagliflozin in CKD

EUROPEAN HEART JOURNAL

IF35.6

2024-10-28

PREAI

Rossing, P.; Hauske, S. J.; Cronin, L.; Heerspink, H. J. L.; Meyerhoff, J.; Ji, B.; De Zeeuw, D.; Tuttle, K. R.

Save

Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease: A Systematic Review and Retrospective Individual Participant-Level Meta-analysis of Clinical Trials

ANNALS OF INTERNAL MEDICINE

IF15.2

2024-07-01

PREAI

Ku, Elaine; Inker, Lesley A.; Tighiouart, Hocine; McCulloch, Charles E.; Adingwupu, Ogechi M.; Greene, Tom; Estacio, Raymond O.; Woodward, Mark; de Zeeuw, Dick; Lewis, Julia B.; Hannedouche, Thierry; Jafar, Tazeen H.; Imai, Enyu; Remuzzi, Giuseppe; Heerspink, Hiddo J. L.; Hou, Fan Fan; Toto, Robert D.; Li, Philip K.; Sarnak, Mark J.

Save

Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial

DIABETES OBESITY & METABOLISM

IF5.7

2024-06-19

PREAI

Cardoza, Kathryn; Kang, Amy; Smyth, Brendan; Yi, Tae Won; Pollock, Carol; Agarwal, Rajiv; Bakris, George; Charytan, David M.; de Zeeuw, Dick; Wheeler, David C.; Zhang, Hong; Cannon, Christopher P.; Perkovic, Vlado; Arnott, Clare; Levin, Adeera; Mahaffey, Kenneth W.

Save

Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF9.4

2024-06-18

PREAI

Ku, Elaine; Tighiouart, Hocine; Mcculloch, Charles E.; Inker, Lesley A.; Adingwupu, Ogechi M.; Greene, Tom; Estacio, Raymond O.; Woodward, Mark; de Zeeuw, Dick; Lewis, Julia B.; Hannedouche, Thierry; Hou, Fan Fan; Jafar, Tazeen H.; Imai, Enyu; Remuzzi, Giuseppe; Heerspink, Hiddo J. L.; Toto, Robert D.; Sarnak, Mark J.

Save

Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial

DIABETES OBESITY & METABOLISM

IF5.7

2024-03-18

OAAI

Bornstein, Stefan R.; de Zeeuw, Dick; Heerspink, Hiddo J. L.; Schulze, Friedrich; Cronin, Lisa; Wenz, Arne; Tuttle, Katherine R.; Hadjadj, Samy; Rossing, Peter

Save

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

LANCET

IF88.5

2024-01-01

OAAI

Tuttle, Katherine R.; Hauske, Sibylle J.; Canziani, Maria Eugenia; Caramori, Maria Luiza; Cherney, David; Cronin, Lisa; Heerspink, Hiddo J. L.; Hugo, Christian; Nangaku, Masaomi; Rotter, Ricardo Correa; Silva, Arnold; Shah, Shimoli, V; Sun, Zhichao; Urbach, Dorothea; de Zeeuw, Dick; Rossing, Peter

Save

Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease

KIDNEY INTERNATIONAL

IF12.6

2023-12-01

OAAI

Chan, Kam Wa; Smeijer, J. David; Schechter, Meir; Jongs, Niels; Vart, Priya; Kohan, Donald E.; Gansevoort, Ron T.; Liew, Adrian; Tang, Sydney C. W.; Wanner, Christoph; de Zeeuw, Dick; Heerspink, Hiddo J. L.

Save

Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in CKD

AMERICAN JOURNAL OF NEPHROLOGY

IF3.2

2023-10-30

OAAI

Tuttle, Katherine R.; Rossing, Peter; Hauske, Sibylle J.; Cronin, Lisa; Hussain, Joanna; de Zeeuw, Dick; Heerspink, Hiddo J. L.

Save

Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease

CARDIOVASCULAR DIABETOLOGY

IF10.6

2023-09-16

OAAI

Smeijer, J. David; Kohan, Donald E.; Rossing, Peter; Correa-Rotter, Ricardo; Liew, Adrian; Tang, Sydney C. W.; de Zeeuw, Dick; Gansevoort, Ron T.; Ju, Wenjun; Heerspink, Hiddo J. Lambers

Save

The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial

DIABETES OBESITY & METABOLISM

IF5.7

2023-09-06

OAAI

Yu, Jie; Sweeting, Arianne N.; Gianacas, Chris; Houston, Lauren; Lee, Vivian; Fletcher, Robert A.; Perkovic, Vlado; Li, Qiang; Neuen, Brendon L.; Berwanger, Otavio; Heerspink, Hiddo J. L.; de Zeeuw, Dick; Arnott, Clare

Save

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2023-07-01

OAAI

Yi, Tae Won; Smyth, Brendan; Di Tanna, Gian Luca; Arnott, Clare; Cardoza, Kathryn; Kang, Amy; Pollock, Carol; Agarwal, Rajiv; Bakris, George; Charytan, David M.; de Zeeuw, Dick; Heerspink, Hiddo J. L.; Neal, Bruce; Wheeler, David C.; Cannon, Christopher P.; Zhang, Hong; Zinman, Bernard; Perkovic, Vlado; Levin, Adeera; Mahaffey, Kenneth W.; Jardine, Meg

Save

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2023-06-13

OAAI

Charytan, David M.; Mahaffey, Kenneth W.; Jardine, Meg J.; Cannon, Christopher P.; Neal, Bruce; Heerspink, Hiddo J. Lambers; Agarwal, Rajiv; Bakris, George L.; de Zeeuw, Dick; Levin, Adeera; Pollock, Carol; Zhang, Hong; Zinman, Bernard; Rosenthal, Norman; Perkovic, Vlado; Di Tanna, Gian Luca; Yu, Jie; Rogers, Kris; Arnott, Clare; Wheeler, David C.

Save

Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial

DIABETES OBESITY & METABOLISM

IF5.7

2023-05-25

OAAI

Cherney, David Z. I.; de Zeeuw, Dick; Heerspink, Hiddo J. L.; Cardona, Jose; Desch, Marc; Wenz, Arne; Schulze, Friedrich; Nangaku, Masaomi

Save

The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials

DIABETES OBESITY & METABOLISM

IF5.7

2023-05-10

OAAI

Kang, Amy; Smyth, Brendan; Neuen, Brendon L. L.; Heerspink, Hiddo J. L.; Di Tanna, Gian Luca; Zhang, Hong; Arnott, Clare; Hockham, Carinna; Agarwal, Rajiv; Bakris, George; Charytan, David M. M.; de Zeeuw, Dick; Greene, Tom; Levin, Adeera; Pollock, Carol; Wheeler, David C. C.; Mahaffey, Kenneth W. W.; Perkovic, Vlado; Jardine, Meg J. J.

Save

Research Directions